Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04165330
Title Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC

lung small cell carcinoma

lung non-small cell carcinoma


Advanced Solid Tumor


Anlotinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.